Since its creation in 2017, Hepatitis C: State of Medicaid Access has evaluated hepatitis C treatment policies across state Medicaid programs. In response to advocacy and litigation, many states have reduced or eliminated their restrictions, but significant barriers remain in a majority of jurisdictions. Join us and our partners at the National Viral Hepatitis Roundtable on February 16 for our latest snapshot of the national HCV treatment landscape and our team’s insights into the road that lies ahead.